RECKITT BENCKISER GROUP PLC
No SEC Form 4 filings for $RBGLY in the last 30 days.
See all $RBGLY insider activity →Synergy CHC Corp., maker of Focus Factor, filed for bankruptcy after Costco ended their 16-year partnership, costing Synergy 58% of its 2025 net revenue. Reckitt Benckiser (RBGLY) is positioned to benefit, as its Neuriva brain supplement is already sold at Costco. RBGLY trades at $14, down 10.62% year-to-date, with H1 2026 revenue growth of 2.7%.
Over the past 7 days, AlphAI's AI scored 1 news story mentioning RBGLY (RECKITT BENCKISER GROUP PLC). Coverage has skewed bearish: 0 bullish, 0 neutral, and 1 bearish.
Potential revenue uplift for RBGLY from increased Neuriva sales at Costco.
AlphAI scores every news story that mentions RBGLY with an AI model for sentiment and relevance, and aggregates insider trades from RECKITT BENCKISER GROUP PLC's SEC EDGAR Form 4 filings. Figures refresh continuously.
Synergy CHC Corp., maker of Focus Factor, filed for bankruptcy after Costco ended their 16-year partnership, costing Synergy 58% of its 2025 net revenue. Reckitt Benckiser (RBGLY) is positioned to benefit, as its Neuriva brain supplement is already sold at Costco. RBGLY trades at $14, down 10.62% year-to-date, with H1 2026 revenue growth of 2.7%.
2 min read
